661 related articles for article (PubMed ID: 26694349)
1. Unfolded Protein Response and Macroautophagy in Alzheimer's, Parkinson's and Prion Diseases.
Milisav I; Šuput D; Ribarič S
Molecules; 2015 Dec; 20(12):22718-56. PubMed ID: 26694349
[TBL] [Abstract][Full Text] [Related]
2. Redox control of protein degradation.
Pajares M; Jiménez-Moreno N; Dias IHK; Debelec B; Vucetic M; Fladmark KE; Basaga H; Ribaric S; Milisav I; Cuadrado A
Redox Biol; 2015 Dec; 6():409-420. PubMed ID: 26381917
[TBL] [Abstract][Full Text] [Related]
3. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
4. From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins.
Marrero-Winkens C; Sankaran C; Schätzl HM
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32927676
[TBL] [Abstract][Full Text] [Related]
5. Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.
Salahuddin P; Fatima MT; Abdelhameed AS; Nusrat S; Khan RH
Eur J Med Chem; 2016 May; 114():41-58. PubMed ID: 26974374
[TBL] [Abstract][Full Text] [Related]
6. The stress rheostat: an interplay between the unfolded protein response (UPR) and autophagy in neurodegeneration.
Matus S; Lisbona F; Torres M; León C; Thielen P; Hetz C
Curr Mol Med; 2008 May; 8(3):157-72. PubMed ID: 18473817
[TBL] [Abstract][Full Text] [Related]
7. Natural Products as Modulators of the Proteostasis Machinery: Implications in Neurodegenerative Diseases.
Cuanalo-Contreras K; Moreno-Gonzalez I
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547084
[TBL] [Abstract][Full Text] [Related]
8. Microglial cells in neurodegenerative disorders.
Wojtera M; Sikorska B; Sobow T; Liberski PP
Folia Neuropathol; 2005; 43(4):311-21. PubMed ID: 16416395
[TBL] [Abstract][Full Text] [Related]
9. Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology.
Wiersma VI; van Hecke W; Scheper W; van Osch MA; Hermsen WJ; Rozemuller AJ; Hoozemans JJ
Acta Neuropathol Commun; 2016 Oct; 4(1):113. PubMed ID: 27793194
[TBL] [Abstract][Full Text] [Related]
10. The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy.
Shacka JJ; Roth KA; Zhang J
Front Biosci; 2008 Jan; 13():718-36. PubMed ID: 17981582
[TBL] [Abstract][Full Text] [Related]
11. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
Gaggelli E; Kozlowski H; Valensin D; Valensin G
Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441
[No Abstract] [Full Text] [Related]
12. Insights into Mechanisms of Chronic Neurodegeneration.
Diack AB; Alibhai JD; Barron R; Bradford B; Piccardo P; Manson JC
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26771599
[TBL] [Abstract][Full Text] [Related]
13. The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration.
Maïza A; Chantepie S; Vera C; Fifre A; Huynh MB; Stettler O; Ouidja MO; Papy-Garcia D
FEBS Lett; 2018 Dec; 592(23):3806-3818. PubMed ID: 29729013
[TBL] [Abstract][Full Text] [Related]
14. Activation of the unfolded protein response is an early event in Alzheimer's and Parkinson's disease.
Hoozemans JJ; van Haastert ES; Nijholt DA; Rozemuller AJ; Scheper W
Neurodegener Dis; 2012; 10(1-4):212-5. PubMed ID: 22302012
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-beta (Aβ₁₋₄₂)-induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways.
Regitz C; Dußling LM; Wenzel U
Mol Nutr Food Res; 2014 Oct; 58(10):1931-40. PubMed ID: 25066301
[TBL] [Abstract][Full Text] [Related]
16. Does perturbation in the mitochondrial protein folding pave the way for neurodegeneration diseases?
Ji T; Zhang X; Xin Z; Xu B; Jin Z; Wu J; Hu W; Yang Y
Ageing Res Rev; 2020 Jan; 57():100997. PubMed ID: 31816444
[TBL] [Abstract][Full Text] [Related]
17. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.
Di Domenico F; Barone E; Perluigi M; Butterfield DA
Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216
[TBL] [Abstract][Full Text] [Related]
18. Differential protein expression in diverse brain areas of Parkinson's and Alzheimer's disease patients.
Esteves AR; Cardoso SM
Sci Rep; 2020 Aug; 10(1):13149. PubMed ID: 32753661
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Excessive Oxidative Protein Folding Is Protective in MPP(+) Toxicity-Induced Parkinson's Disease Models.
Lehtonen Š; Jaronen M; Vehviläinen P; Lakso M; Rudgalvyte M; Keksa-Goldsteine V; Wong G; Courtney MJ; Koistinaho J; Goldsteins G
Antioxid Redox Signal; 2016 Sep; 25(8):485-97. PubMed ID: 27139804
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
